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Abstract
Extremely low birth weight infants (ELBW) are defined by birth weight of less 
than 1000 g and are frequently born at 27 weeks’ gestation (GW) or younger. The 
neonatologists’ efforts focused on improvement of intact survival rate, especially 
for those born at the frontiers of viability at 22/23 GW. Survival rates of >80% 
for the advanced gestations and > 50% for 23–24 GW have been reported. Higher 
gestational age and birth weight, female gender, better maternal education, and 
white race have been recognized as significant predictors of decreased morbidity 
in ELBW infants. Although the mortality rate has significantly contracted for this 
group with improved technology and better understanding of pathophysiology, the 
proportion of surviving infants without sequelae, has not improved as noticeably. 
We review the short and long-term morbidities in ELBW infants and compare own 
and literature data. We analyze some of the specific immediate problems for this 
group such as: respiratory problems, infection, thermoregulation, impaired glucose 
homeostasis and disturbed cardiovascular and excretory functions as well as late 
morbidities such as bronchopulmonary dysplasia, late-onset infections, central 
nervous system occurrences, retinopathy and anemia of prematurity. We also deal 
with preventive and therapeutic strategies for improved outcome in this sensitive 
group of patients.
Keywords: ELBW infants, survival, morbidities, outcomes, respiratory distress, 
bronchopulmonary dysplasia, retinopathy of prematurity
1. Introduction
Prematurity is a significant risk factor for survival of the neonate and is related 
to increased perinatal mortality and morbidity. Current minimal age of viability is 
considered to be 22–23 weeks’ gestation with dispersed reports of survival earlier 
than this estimated gestational age (GA) [1].
Extremely low birth weight infants (ELBW) are defined by birth weight of less 
than 1000 g; also, are the youngest premature newborns typically born at 27 weeks’ 
gestation or younger [1].
Attention has turned to the improvement of the intact survival rate of extremely 
low birth weight infants (ELBW), particularly of those born at the boundaries 
of current perinatal medicine. Survival rates to hospital discharge of above 80% 
have been reported in Canada, USA and Japan for the 25 GW [2–4]. Developed 
centers report on increase survival rates also for infants born at 23–24 GW [4] 
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with significant variability in survival observed in resource limited centers [5, 6]. 
Factors found to be significantly positively correlated with improved survival and 
outcome of ELBW infants were: older gestational age [1, 5, 6], higher birth weight 
[1, 5–7], female gender [7], singleton birth [7], antenatal steroid use [1, 6–8], 
Apgar score at 5 min [1] and delivery by cesarean section (CS) [1, 6]. On the other 
hand, vaginal delivery in non-vertex presentation [1, 9, 10] placental abruption [1] 
and the existence of fetal growth restriction [11] have been recognized as adverse 
factors. Reports highlight birth weights of >750 g in association with better survival 
[1, 6, 12]. In our previous study, not only that we found a strong positive correla-
tion of higher birth weights with survival, but also of broader head circumferences; 
the median head circumference was 2.5 cm larger for the survivors [12]. Apgar 
scores’ median value 5 at the first minute were significantly positively associated 
with favorable outcome [12]. A significant correlation of caesarean section delivery 
with the outcome has been observed in studies [1, 6, 12], with a higher share of 
emergency cesarean sections in survivors [12] pointing out that CS is indeed a 
protective mode of delivery. However, indication of CS in pregnancies of less than 
24 weeks is a matter of inclusive worldwide debate. To reach a conclusion, a nation-
wide survey is needed.
Although the mortality rate has significantly diminished with improved 
neonatal technologies, use of exogenous surfactant preparations and better under-
standing of pathophysiology of ELBW infants, the proportion of surviving infants 
without sequelae, such as chronic lung disease, cognitive delays, cerebral palsy and 
neurosensory deficits has not improved as noticeably [13, 14].
2. Specific problems in the ELBW infants
2.1 Thermoregulation
ELBW infants are particularly prone to heat loss immediately after birth due 
to high body surface area to weight ratio, thin skin, decreased brown fat tissue 
and decreased glycogen supply. Studies have found significant association of 
hypothermia to in-hospital mortality, respiratory distress syndrome, necrotizing 
enterocolitis (NEC), and intraventricular hemorrhage in low birth weight/preterm 
infants [15, 16]. A retrospective observational study performed at 29 Canadian 
Neonatal Networks’ neonatal intensive care units encompassing 9833 infants born 
at <33 weeks’ gestation showed U-shaped relationship between admission tempera-
tures and adverse neonatal outcomes. Lowest rates of adverse outcomes have been 
associated with admission temperatures between 36.5 °C and 37.2 °C [15]. Thermal 
management is crucial for survival of the ELBW infants and includes interventions 
such as drying, heating under a radiant warmer, placing a hat on the head and plas-
tic film over the body [16, 17]. Frequent monitoring of temperature should be done 
to avoid iatrogenic hyperthermia, especially when applying multiple interventions 
simultaneously (e.g. plastic bags + thermal mattresses) [16].
2.2 Respiratory distress syndrome
Respiratory distress syndrome (RDS) caused by surfactant deficiency is an 
early complication of extreme prematurity. Surfactant deficiency causes decreased 
pulmonary compliance, alveolar hypotension, and an imbalance between pul-
monary ventilation and perfusion [17, 18]. Clinically marked by tachypnea, chest 
retractions, nasal flaring, cyanosis and grunting, this condition usually progresses 
to hypoventilation, hypoxemia and respiratory acidosis [17, 18]. RDS was recorded 
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in 80% of babies born at 28 weeks’ gestation and in 90% of those born at 24 weeks’ 
gestation according to Vermont Oxford Network data during 2017 [18]. Common 
complications of RDS comprise air leak syndromes, bronchopulmonary dysplasia 
(BPD) and retinopathy of prematurity (ROP). Animal and synthetic surfactants 
have been widely used for the treatment of RDS which resulted with significant 
reduction in mortality. Also, a shift in practice has been noted towards non-invasive 
ventilation techniques such as continuous positive airway pressure CPAP [19]. 
Recent large trials showed a lower risk of chronic lung disease or death from early 
stabilization on CPAP with selective surfactant administration [20]. However, 
infants born at 23–24 weeks’ gestation, may continue to have high need for intuba-
tion during initial stabilization.
The INSURE technique (Intubate-Surfactant-Extubate) for surfactant adminis-
tration involves giving surfactant through an endotracheal tube while administer-
ing positive pressure inhalations, often with premedication. This method has been 
used since 1994 and efficacy has been replicated in many studies [21, 22]. LISA 
(Less Invasive Surfactant Administration) on the other hand, is a preferred new 
method that involves administering surfactant via a small intratracheal catheter, 
with the baby breathing spontaneously on CPAP or NIPPV support, without seda-
tion [23, 24]. However, a recent study raised concerns over relatively low success 
rate of the first LISA attempt, often inadequate technical performance quality and 
recurrent desaturations [24].
Following the increasing use of CPAP, other non-invasive ventilation methods 
have been subjected to research, mostly nasal intermittent positive pressure ventila-
tion (NiPPV) [25] and high-flow nasal cannula (HFNC). Trials have failed to show 
difference in rates of death and BPD when NiPPV was compared to CPAP [26, 27]. 
HFNC has been considered as an alternative non-invasive mode for post-extubating 
support [28]. Current mechanical ventilation (MV) tactics include shortening of 
duration of MV and the use of targeted volume ventilation (VT). VT results in 
shorter ventilation-time, fewer air-leaks and less BPD [17].
2.3 Cardiovascular problems
2.3.1 Patent ductus arteriosus
Up to 80% of ELBW infants have a clinically significant patent ductus arteriosus 
(PDA). As a consequence of the left-to-right systemic to pulmonary shunting vari-
ous symptoms may appear, most notably, systolic murmur, hypotension, bounding 
pulses, decreased urine output, pulmonary hyperemia and edema, as well as and 
reduced mesenteric and cerebral perfusion [29]. Contrary to term newborn who 
exhibit spontaneous ductus closure in 90% at 48 hours, it occurs in only 30 to 35% 
of infants with BW < 1000 grams during the neonatal period [29].
The diagnosis is set by echocardiography, also Doppler ultrasound of the cere-
bral blood vessels in search for signs of diminished perfusion. Ideal management 
of the PDA in premature infants is still a topic of debate, despite more than three 
decades of active study [29, 30]. Indomethacin was the conventional drug of choice 
for ductus closure, but concerns regarding its negative effects on cerebral, renal and 
gastrointestinal perfusion have led to investigation of other agents such as ibupro-
fen [30]. A 2020 Cochrane review concluded equal effectiveness of ibuprofen and 
indomethacin in closing a PDA. However, in the light more favorable safety profile, 
ibuprofen was highlighted the drug of choice with an equal effectiveness of oro-
gastric and intravenous administration [31]. Oral paracetamol was also supported 
by clinical studies as equally potent drug for ductus closure [32]. Surgical ligation 




Blood pressure (BP) of preterm newborns is marked with wide range of 
observed values for every GA. It is generally accepted that lower BP values are seen 
with decreasing gestational age and birth weight. Usually, mean arterial blood 
pressure corresponds to the gestational age, but this relationship is less clear for 
the extremely premature infants [33]. The variations in BP are related to dynamic 
changes in physiology during neonatal transition and various disease processes 
in this group of patients. It has not been proven that institution of any kind of 
anti-hypotensive therapy, fluid bolus or dopamine could significantly influence 
the rise of BP 4–24 hours after birth. Therefore, it has been suggested not to rely on 
a single numerical BP cutoff value for predicting infants that could benefit from 
anti-hypotensive treatments [33].
Recent randomized controlled trial could not show differences in hemodynamic 
parameters, amplitude integrated EEG variables, clinical complications or brain 
ultrasound findings between groups of active, moderate or permissive BP treat-
ment of patients ≤29 GW [34]. The last composite guideline for management of 
neonatal respiratory distress syndrome recommends treatment of hypotension 
when evidenced by signs of poor tissue perfusion such as oliguria or poor capillary 
return, rather than treating sole numerical values [17]. Dopamine has been found 
more efficient than dobutamine for treatment of systemic hypotension in preterm 
infants, while dobutamine and epinephrine could be opted for treatment of reduced 
ventricular function [35]. Hydrocortisone is an alternative medicament for treat-
ment of hypotension in extremely preterm infants [36].
Hypovolemic shock should be managed by giving non-cross-matched 
O-Rhesus-negative blood or alternatively by administering an isotonic crystalloid 
solution; the proposed dose is 10–20 mL/kg [37]. Delayed cord clamping apart 
from expanding blood volume, was proven in clinical studies to yield multiple 
potential benefits for preterm infants such as improved neurodevelopmental out-
comes, reduced blood transfusions, possible autologous transfusion of stem cells, 
and reduced incidence of intraventricular hemorrhage [38]. However, in infants 
who need immediate resuscitative measures, it is recommended that placental 
transfusion should be discontinued [37].
2.4 Central nervous system problems
Intraventricular hemorrhage (IVH) is an extravasation of blood in the brain 
that originates from the subependymal germinal matrix and advances into the 
ventricular system, most frequently occurring in the first 3 days of life [39]. The 
classical grading system of the extent of cerebral bleeding includes 4 grades of 
hemorrhages: grade I - confined to the germinal matrix, grade II – progression to 
the lateral ventricle without ventricle dilatation, grade III – blood in the ventricle 
results in ventricular dilatation, grade IV – periventricular hemorrhagic infarction. 
Our study group reported an incidence of IVH in almost a third of the ELBW cohort 
[12]. An inverse relationship exists between the incidence and severity of IVH and 
gestational age; the lowermost gestations and weights are most heavily affected.
IVH has been recognized as one of the crucial morbidities in ELBW infants, 
with serious potential short-term sequelae in survivors such as hemorrhagic peri-
ventricular infarction, post-hemorrhagic hydrocephalus or seizures, and in the long 
term, developmental delay, cerebral palsy, deafness, and blindness. [40]. A shift to 
milder forms of neurosensory impairment has been noted reflecting better practices 
in perinatal care [41]. Generally, a straightforward correlation exists between the 
IVH grade and its prognosis. However, close neurodevelopmental follow-up is also 
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required for infants assigned to grades I and II IVH. Associations have been found 
between low-grade hemorrhages and reduced cortical volume at near term age [42]. 
Likewise, adverse neurodevelopmental outcomes for grades I and II IVH have been 
observed in follow up studies [41]. Forty four percent of ELBW children with grades 
III and IV intracranial hemorrhage present with disabling cerebral palsy (CP), and 
45–85% of children with grade IV intracranial hemorrhage have mental retardation 
and CP at school age [43].
Periventricular leukomalacia (PVL) is damage to the periventricular white 
matter developed as a result of perinatal adverse insults such as hypoxia, hypo 
or hyper-perfusion, hypocarbia and chorioamnionitis combined with the defec-
tive cerebral vascular autoregulation in preterm infants. The estimated incidence 
of PVL is 4–15% in ELBW babies. We demonstrated an incidence of 19% in our 
ELBW cohort [44]. While strong correlation has been observed between diffuse 
cystic PVL and cerebral palsy, the clinical correlates of diffuse white mater inju-
ries and localized cysts are not so clear-cut and might be related to a spectrum of 
behavioral/cognitive deficits [43].
2.5 Renal problems
Preterm infants exhibit increased sensitivity to impaired renal function. This is 
due to enhanced kidney maturation, fewer functional nephrons and higher renal 
filtration rate [45]. Acute kidney injury (AKI) in preterm infants can cause long-
lasting renal damage leading to chronic kidney disease in adulthood [46]. Extremely 
premature infants are prone to developing AKI in the first days of life. Serum 
creatinine levels reflect maternal levels immediately after birth. Serum creatinine 
then picks, reaches a plateau in the first days of life, and declines thereafter. ELBW 
infants with AKI showed reduced survival until 36 weeks of post-menstrual age 
(PMA) [45]. Fluid status monitoring is a paramount. It involves daily monitoring of 
electrolytes, body weight, diuresis, blood pressure and insensible water loss.
2.6 Electrolyte imbalance
The ELBW infant is made up of 85% to 90% water, which is predominantly 
distributed in the extracellular space. During the first few postnatal days a 
weight loss of 10–20% is observed which is attributable to diuresis and can be 
intensified by iatrogenic causes such as radiant warmers or phototherapy. These 
developments in addition to the compromised renal function constitute a setting 
for frequent electrolyte abnormalities such as hypo/hypernatremia and hyper-
kalemia [47]. Disturbances of sodium are connected to the water flow and can 
either be presented with hypernatremia if significant amount of water is lost due 
to heating and phototherapy or with dilutional hyponatremia. Hyperkalemia, on 
the other hand, is a result of shifting from the intracellular to the extracellular 
compartment [47].
2.7 Impaired glucose homeostasis
Early hypoglycemia is a frequent occurrence in ELBW infants because of 
limited liver glycogen stores and immature endocrine mechanisms of blood 
glucose’s control. In particular, ketogenesis and lipogenesis which lead to the 
production of alternative energy fuels, are limited for this group of patients, 
making them more dependent on glucose. Clinical conditions that are associated 
with hypoglycemia such as perinatal asphyxia, acidosis, sepsis and hypothermia 
are common [48]. Moreover, hypoglycemia in extremely preterm infants is rarely 
Caesarean Section
6
accompanied by symptoms typical for term counterparts such as jitteriness, 
lethargy, apnea or poor feeding.
Hyperglycemia is also observed in extremely premature infants and in those 
with intrauterine growth retardation (IUGR). This condition is usually the result of 
excessive glucose infusion rates, drug treatment by steroids or methylxanthines, or 
may reflect the immaturity of the regulatory mechanisms [48].
2.8 Infection
Early-onset neonatal infection (EOI), defined as one typically occurring in the 
first 72 hours of life, significantly contributes to the morbidity and mortality of 
ELBW infants with an estimated incidence of 26 per 1000 live ELBW births in US 
[49]. High index of suspicion of a possible intrauterine infection should be main-
tained in the presence of a premature birth. Current efforts are directed toward 
intrapartum antimicrobial prophylaxis and early neonatal infectious screening. 
Early-onset infection initiates with newborn’s colonization with bacteria from the 
maternal genital tract, most commonly group B streptococcus, E. coli and Listeria 
[49]. Also, other Gram-positive or Gram-negative bacteria, as well as fungi and 
viruses can contribute to the microbial spectrum of EOI.
Late-onset sepsis (LOS) results from horizontal transmission of endogenous 
hospital flora and typically occurs after the first week of life. Frequent nosocomial 
pathogens are coagulase-negative staphylococci, Klebsiella and Pseudomonas spe-
cies as well as methicillin-resistant Staphylococcus aureus (MRSA) and fungi [50, 51]. 
Many institutions, including ours follow a fluconazole prophylaxis protocol for the 
duration of the central catheters in order to reduce catheter-associated fungaemia 
[51]. Our institutions’ low incidence of detection of fungal sepsis (3%) among 
LOS is attributable to strict adherence to this Candida-prophylaxis policy [44]. 
Predisposing factors for late-onset infections include: immaturity of the immune 
system, thin permeable skin and mucous membranes, ventilator care, parenteral 
nutrition, central venous catheters and tubes, overcrowded nursery, inadequate 
hand washing routine as well as exposure to extensive handling.
Neonatal infection in ELBW infants has been associated with poor neurodevel-
opmental and growth outcomes in early childhood according to results of a large-
cohort follow-up study [14]. Symptoms of infection in preterm newborns often 
include: apnea, bradycardia and cyanosis, also lethargy and increased respiratory 
effort, symptoms being more pronounced with Gram-negative and fungal infec-
tions than with Gram-positive ones [49]. Treatment consists of first line therapy 
with ampicillin and gentamycin for EOI. If the mother’s vaginal swab was positive 
for a Gram-negative bacterium such as E. coli, the protocol can be revised to cefo-
taxime and gentamycin. Vancomycin and gentamicin are used for treating LOS and 
may be adjusted according to microbial sensitivity of the hemoculture. When resis-
tant septic shock is observed ceftazidime or imipenem should be urgently added. 
Fluconazole or amphotericin B are given for suspected or proven fungal infections.
2.9 Bronchopulmonary dysplasia
Bronchopulmonary dysplasia (BPD) was traditionally considered as oxygen 
and respirator-mediated injury related to prematurity. However, gentler ventilator 
techniques, prenatal corticosteroid therapy and treatment with surfactants have 
limited more severe lung injuries to infants of <1200 g BW and < 30 week’ gestation 
[52]. BPD traditionally defined as a need for supplemental oxygen or ventilator 
support at 36 weeks’ post menstrual age (PMA) occurs with an incidence of around 
30% in ELBW infants [53].
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In 2001, a new revised definition of BPD was devised by the National Institute of 
Child Health and Human Development (NICHD) categorizing the disease severity 
as mild, moderate, or severe based solely on oxygen dependency level at <32 GW. 
Mild BPD was defined by breathing room air at 36 weeks post menstrual age or dis-
charge, moderate BPD equaled breathing <30% oxygen, and severe corresponded 
to breathing >30% oxygen or receiving positive pressure ventilation at PMA of 
36 weeks. Radiographic findings were not included in the new definitions due to 
inconsistent interpretations and deficient availability at certain ages [52].
Infants with BPD were found to have higher rates of adverse neurodevelop-
mental outcomes and cognitive impairment in early childhood compared to those 
without BPD [53, 54]. At school age, children with BPD were recognized with 
growth impairment and academic difficulties [55]. Common rehospitalizations have 
been observed during the first 2 years of life, mostly as a consequence of respiratory 
illnesses including lower respiratory tract infections and RSV bronchiolitis [56]. 
RSV prophylaxis with palivizumab is included as standard care for BPD children in 
the first year of life.
2.10 Retinopathy of prematurity
Retinopathy of prematurity (ROP) represents interruption of the natural course 
of vascularization of the premature retina caused by oxygen exposure with conse-
quent pathological compensation that results in abnormal neo-vascularization of 
the retina. Hence, prematurity and treatment with oxygen are the two main recog-
nized risk factors for ROP.
Hyperoxia has been an enormous concern in the neonatal intensive care units, 
and the optimal oxygen saturation target ranges have been debated and explored in 
studies [57]. Results from several studies suggested possible harmful effect of oxy-
gen saturation targets of 91–95%, on the contrary, lower target ranges of 85–89% 
resulted in increased mortality [57, 58]. Therefore, it has been recommended target-
ing saturations between 90 and 94% by setting alarm limits between 89 and 95%, 
though recognizing that ideal oxygen saturation targets are still unknown [17].
Variable incidence of retinopathy of prematurity has been reported in popu-
lation-based studies due to variability in study designs and gestational ages of the 
included infants; reported incidences vary from 10–75% in different studies [59]. 
An incidence of 17.1% of severe ROP in the survivor’s subcategory was reported by 
our group. The average number of blood transfusions for this group was 7 [44].
Severe ROP is defined by a unilateral or bilateral stage 4 or 5 disease or disease 
requiring laser/anti-vascular endothelial growth factor (anti-VEGF) monoclonal 
antibody treatment, at least unilaterally. The timing of onset of ROP depends on 
both the gestational and the chronological age, whereas the diseases’ incidence and 
severity are inversely proportional to both birth weight and gestational age [59]. 
Apart from oxygen, suggested adverse impacts that might predispose to retinopathy 
of prematurity are intrauterine infection, hyperglycemia, neonatal infection, prob-
ably due to systemic inflammation, being born small for gestational age, and also 
repeated blood transfusions [59, 60].
Current joint recommendation of the relevant American expert societies 
outlines that indirect ophthalmoscopy screening for ROP should be commenced by 
31 weeks PMA for infants born at 22–27 weeks and repeated in scheduled intervals 
thereafter. Also, all infants of <1500 g and < 30 weeks’ gestation, and at-risk infants 
>30 weeks’ gestation ought to be included in the ROP screening process [61].
Current treatment options include laser photocoagulation, intraocular injec-
tion of anti-VEGF treatment and vitrectomy. Parallel to the increased survival 
of the most immature infants, the number of survivors with severe ROP has also 
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increased. However, blindness has become a rare consequence of the most severe 
disease cases. Infants with ROP exhibit other ophthalmological problems such as 
myopia, strabismus and astigmatism [59]. Apart from visual disturbances, ROP 
alone or in association with other problems of the premature infants can lead to 
neurodevelopmental difficulties and lower academic performances [54, 55].
2.11 Anemia of prematurity
Anemia of prematurity (AOP) is a condition specific to premature infants 
caused by a combination of physiologic reasons such as depleted iron stores, shorter 
life span of erythrocytes, immature erythropoietic response, vitamin B12 and folate 
deficiencies as well as rapid postnatal growth, combined with iatrogenic causes 
observed in frequent phlebotomies for laboratory studies. Treatment of anemia 
consists of transfusions with erythrocyte concentrates.
Early administration of erythropoietin in the first week of life has not proven to 
significantly reduce the need for blood transfusions, but instead increases the risk 
of severe ROP [62]. Positive association has been found between anemia in the first 
week of life and the number of required blood transfusions with ROP development 
[60]. The proposed mechanism of progressing ROP is the replacement of hemoglo-
bin F with hemoglobin A during blood transfusion which sharply increases oxygen 
availability to the retina [63].
Recommended transfusion thresholds are the following: hemoglobin (Hb) 12 g/
dL /hematocrit (HTC) 36% for severe cardiopulmonary disease, Hb 11 g/dL /HCT 
30% when dependent on oxygen and Hb 7 g/dL/HCT 25% when clinically stable 
beyond 2 weeks of age [17]. To decrease the risk of transfusion-related infection, 
a single donors’ unit of packed red blood cells should be used, divided into several 
satellite bags to be used for the same patient for several weeks [64].
Other problems of the ELBW spectrum include: apnea of prematurity, gastroin-
testinal problems, feeding intolerance, hyperbilirubinemia, necrotizing enteroco-
litis, inguinal hernias, total parenteral nutrition-associated cholestatic jaundice as 
well as postnatal growth restriction [65].
3. Conclusion
The mortality rate of ELBW infants significantly diminished with improved 
technology and improved neonatal practices, however there are still many issues 
to be covered for optimal complete approach to these patients that would reduce 
not just the immediate, but also the long-term consequences. A multidisciplinary 
approach to treatment and follow up of these children is necessary, with special 
focus of the most sensitive areas of care such as neurodevelopmental, cognitive, 
auditory, visual, respiratory, speech and language, behavioral and emotional. 
Providing a family-centered care and structuring of appropriate data basis is 
necessary.
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